1. Home/
  2. Compounds/
  3. navitoclax:sorafenib (1:1 mol/mol)

navitoclax:sorafenib (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:sorafenib (1:1 mol/mol)
PharmacoGx navitoclax:sorafenib (1:1 mol/mol)

Cell lines tested with navitoclax:sorafenib (1:1 mol/mol)

835 cell lines have been tested with this compound, using data from 1 dataset(s).
CAS-1 central nervous system CTRPv21
KPL-1 breast CTRPv21
MKN1 stomach CTRPv21
BFTC-905 urinary tract CTRPv21
BFTC-909 urinary tract CTRPv21
HuCCT1 biliary tract CTRPv21
NMC-G1 central nervous system CTRPv21
ALL-SIL haematopoietic and lymphoid tissue CTRPv21
HDQ-P1 breast CTRPv21
SNU-245 biliary tract CTRPv21
Download CSV

Tissues tested with navitoclax:sorafenib (1:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
central nervous systemCTRPv247
breastCTRPv236
stomachCTRPv231
urinary tractCTRPv222
biliary tractCTRPv26
haematopoietic and lymphoid tissueCTRPv2154
autonomic gangliaCTRPv213
liverCTRPv222
kidneyCTRPv220
pleuraCTRPv28
Download CSV
Download Data as CSV

Top molecular features associated with response to navitoclax:sorafenib (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ARHGAP33 CTRPv2 AAC 0.33 2e-20
mRNA TUBA1A CTRPv2 AAC 0.3 2e-14
mRNA RP11-729L2.2 CTRPv2 AAC 0.29 2e-14
mRNA SMAD4 CTRPv2 AAC 0.28 2e-14
mRNA GOLGA8M CTRPv2 AAC 0.26 2e-14
mRNA CELF4 CTRPv2 AAC 0.28 2e-14
mRNA PRR36 CTRPv2 AAC 0.28 6e-14
mRNA HDHD2 CTRPv2 AAC 0.28 7e-14
mRNA TIFAB CTRPv2 AAC 0.25 8e-14
mRNA CRMP1 CTRPv2 AAC 0.3 9e-14
Download CSV